At a glance
- Originator Roche Palo Alto LLC
- Class Pentanones; Piperidines; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cognition disorders; Irritable bowel syndrome
Most Recent Events
- 05 Sep 2001 No-Development-Reported for Irritable bowel syndrome in USA (Unknown route)
- 05 Sep 2001 No-Development-Reported for Cognition disorders in USA (Unknown route)
- 18 Mar 1998 Preclinical development for Cognition disorders in USA (Unknown route)